[1]
Sapilak, B.J. 2024. Lipid disorders with concomitant hyperuricemia – the scale of the problem and the benefits of fenofibrate. Medycyna Faktow (J EBM). 17, 3(64) (Dec. 2024), 349-354. DOI:https://doi.org/10.24292/01.MF.0324.05.